LLY

826.35

+0.12%↑

UNH

549.29

-5.04%↓

JNJ

149.3

-0.15%↓

NVO

110.78

+1.8%↑

ABBV

176.22

+0.01%↑

LLY

826.35

+0.12%↑

UNH

549.29

-5.04%↓

JNJ

149.3

-0.15%↓

NVO

110.78

+1.8%↑

ABBV

176.22

+0.01%↑

LLY

826.35

+0.12%↑

UNH

549.29

-5.04%↓

JNJ

149.3

-0.15%↓

NVO

110.78

+1.8%↑

ABBV

176.22

+0.01%↑

LLY

826.35

+0.12%↑

UNH

549.29

-5.04%↓

JNJ

149.3

-0.15%↓

NVO

110.78

+1.8%↑

ABBV

176.22

+0.01%↑

LLY

826.35

+0.12%↑

UNH

549.29

-5.04%↓

JNJ

149.3

-0.15%↓

NVO

110.78

+1.8%↑

ABBV

176.22

+0.01%↑

Search

Aurinia Pharmaceuticals Inc

Cerrado

Sector Salud

8.9 1.95

Resumen

Variación precio

24h

Actual

Mínimo

8.72

Máximo

8.98

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+17.89 upside

Dividendos

By Dow Jones

Próximas Ganancias

13 feb 2025

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

179 / 392 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

Aurinia Pharmaceuticals Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

5 dic 2024, 23:57 UTC

Charlas de Mercado

Gold Edges Higher Ahead of U.S. Jobs Report -- Market Talk

5 dic 2024, 23:54 UTC

Principales Noticias

Republicans Embrace DOGE on Capitol Hill -- Update

5 dic 2024, 22:26 UTC

Ganancias

These Stocks Moved the Most Today: Tesla, MicroStrategy, Synopsys, SentinelOne, AeroVironment, American Airlines, Verint, and More -- Barrons.com

5 dic 2024, 22:15 UTC

Principales Noticias

Anthem Backs Off Plans to Deny Anesthesia Claims After Public Backlash -- Barrons.com

5 dic 2024, 22:11 UTC

Principales Noticias

Judge Rejects Boeing Guilty Plea Over DEI Requirement -- 3rd Update

5 dic 2024, 22:02 UTC

Charlas de Mercado

Early November Figures Point to Torrid Home Sales in Canada -- Market Talk

5 dic 2024, 21:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

5 dic 2024, 21:29 UTC

Adquisiciones, fusiones, absorciones

The Best-Performing GE Stock Keeps Getting New Buy Ratings -- Barrons.com

5 dic 2024, 21:23 UTC

Ganancias

Chevron: In Connection With Plans to Achieve $2B to $3B in Structural Cost Reductions by End 2026, Co Expects to Recognize Restructuring Chg of $0.7B to $0.9B After-Tax in 4Q >CVX

5 dic 2024, 21:23 UTC

Ganancias

Chevron: Two-Thirds Downstream Capex Allocated to U.S. Within Total Upstream and Downstream Budgets, $1.5B of Capex Dedicated to Lowering Carbon Intensity of Ops and Growing New Energies Businesses >CVX

5 dic 2024, 21:23 UTC

Ganancias

Chevron: Permian Basin Spend Is Lower Than 2024 Budget and Anticipated Between $4.5B and $5.0B as Production Growth Is Reduced in Favor of Free Cash Flow >CVX

5 dic 2024, 21:23 UTC

Ganancias

Chevron: Downstream Capex Is Expected Approximately $1.2B >CVX

5 dic 2024, 21:23 UTC

Ganancias

Chevron: Upstream Spending Is Expected to Be About $13B, of Which Roughly Two-Thirds Is Allocated to Develop U.S. Portfolio >CVX

5 dic 2024, 21:20 UTC

Principales Noticias

Boeing's 737 MAX Plea Deal Rejected by Judge -- Barrons.com

5 dic 2024, 21:19 UTC

Ganancias

Chevron: Continue to Invest in High-Return, Lower-Carbon Projects That Position the Co to Deliver Free Cash Flow Growth >CVX

5 dic 2024, 21:19 UTC

Ganancias

Chevron: 2025 Capex and Affil Capex Budgets Represent a $2B Yr-over-Yr Reduction >CVX

5 dic 2024, 21:19 UTC

Ganancias

Chevron: Organic Cap Expenditure Range of $14.5B to $15.5B for Consolidated Subsidiaries and an Affil Cap Expenditure Range of $1.7B to $2.0B for 2025 >CVX

5 dic 2024, 21:19 UTC

Ganancias

Chevron: Restructuring and Other Charges Expected to Be $1.1B to $1.5B in 4Q >CVX

5 dic 2024, 21:19 UTC

Ganancias

Chevron: Announces 2025 Capex Budget & 4Q24 Interim Updates

5 dic 2024, 21:17 UTC

Ganancias

Toronto-Dominion Bank 4Q Rev C$15.51B >TD

5 dic 2024, 21:17 UTC

Ganancias

Toronto-Dominion Bank 4Q Net C$3.64B >TD

5 dic 2024, 21:17 UTC

Ganancias

Toronto-Dominion Bank 4Q Adj EPS C$1.72 >TD

5 dic 2024, 21:17 UTC

Ganancias

Toronto-Dominion Bank 4Q EPS C$1.97 >TD

5 dic 2024, 21:15 UTC

Principales Noticias

Forget 'Drill, Baby, Drill.' Chevron Plans 'Cash, Baby, Cash.' -- Barrons.com

5 dic 2024, 21:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

5 dic 2024, 21:10 UTC

Charlas de Mercado
Ganancias
Adquisiciones, fusiones, absorciones

Bank of Montreal Open to U.S. M&A, But Focus On ROE -- Market Talk

5 dic 2024, 21:00 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

5 dic 2024, 21:00 UTC

Charlas de Mercado

Gold Drops 1% as Market Waits for Jobs Report -- Market Talk

5 dic 2024, 20:47 UTC

Principales Noticias

Republicans Embrace DOGE on Capitol Hill -- WSJ

5 dic 2024, 20:41 UTC

Charlas de Mercado
Ganancias

CIBC Eyes Move Higher in Impaired Provisions in Retail -- Market Talk

Comparación entre iguales

Cambio de precio

Aurinia Pharmaceuticals Inc Esperado

Precio Objetivo

By TipRanks

17.89% repunte

Estimación a 12 meses

Media 10.28 USD  17.89%

Máximo 11 USD

Mínimo 9 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Aurinia Pharmaceuticals Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

4 ratings

4

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

8.69 / 8.83Soporte y Resistencia

Corto Plazo

Very Strong Bearish Evidence

Medio plazo

Weak Bullish Evidence

Largo Plazo

Bullish Evidence

Sentimiento

By Acuity

179 / 392 Clasificación en Salud

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Media

Finanzas

$